FRESH-PEF6396-en
Assessment of lipid-lowering treatment in France
CEPHEUS
| Name | Country code |
|---|---|
| Belgium | be |
| France | fr |
| Greece | gr |
| Ireland | ie |
| Finland | fi |
| Turkey | tr |
| Luxembourg | lu |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Hematology | health theme |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"man or woman - adult - treated with lipid-lowering drugs for at least three months, with no dose adjustment for a minimum of six weeks","clusion_E":""}
| Name |
|---|
| Jean;FERRIERES |
| Name | Role |
|---|---|
| CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE (CHUT) | sponsor |
| ASTRAZENECA (FRANCE) | sponsor |
| Name |
|---|
| ASTRAZENECA (FRANCE) |
| Agency name |
|---|
| CNIL |
| CPP |
['']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2006-01-01 | 2006-12-31 |
One-time cross-sectional study
Contact the principal investigator
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Jean;FERRIERES | jean.ferrieres@utoulouse.fr |